A double blind placebo-controlled randomized phase iii study of high dose continuous infusion cytosine arabinoside (arac) with or without vnp40101m (cloretazine (r)) in patients with first relapse of acute myeloid leukemia (aml)

Norbert, N.; Pigneux, A.; Bošković, Darinka; Kell, J.; Robak, T.; Staib, P.; Johnson, B.; O'Brien, S.; Giles, F.

Results

eNauka > Results > A double blind placebo-controlled randomized phase iii study of high dose continuous infusion cytosine arabinoside (arac) with or without vnp40101m (cloretazine (r)) in patients with first relapse of acute myeloid leukemia (aml)

Title:	A double blind placebo-controlled randomized phase iii study of high dose continuous infusion cytosine arabinoside (arac) with or without vnp40101m (cloretazine (r)) in patients with first relapse of acute myeloid leukemia (aml)
Authors:	Norbert, N.; Pigneux, A.; Bošković, Darinka; Kell, J.; Robak, T.; Staib, P.; Johnson, B.; O'Brien, S.; Giles, F.
Issue Date:	2008
Publication:	Haematologica
ISSN:	0390-6078 Haematologica Search Idenfier
Publisher:	Pavia : Fondazione Ferrata Storti
Type:	Conference Paper
Collation:	br. Vol. 93 str. 13-13
WoS-ID:	000263430200036
VBS COBISS:	1024764341
URI:	https://plus.cobiss.net/cobiss/sr/sr/bib/1024764341#izum.si https://enauka.gov.rs/handle/123456789/705478
M-category:	Mp. category will be shown later

Find the DOI

Finding a DOI in CrossRef based on publication meta-data. The DOI (and metadata) with the similar data match will be displayed. ATTENTION - it doesn't have to be that publication.

Google Scholar^TM